Table 2.
Comparison of incidence and hazard ratio of chronic fatigue syndrome stratified by sex, age and comorbidity between patients with and without peptic ulcer disease.
| Variable | Peptic ulcer disease | Crude HR (95% CI) | Adjusted HR† (95% CI) | |||||
|---|---|---|---|---|---|---|---|---|
| No | Yes | |||||||
| Event | PY | Rate# | Event | PY | Rate# | |||
| All | 313 | 521,915 | 0.60 | 645 | 532,843 | 1.21 | 2.01(1.75, 2.30)*** | 1.83(1.59, 2.11)*** |
| Sex | ||||||||
| Female | 158 | 274,642 | 0.58 | 352 | 282,402 | 1.25 | 2.15(1.79, 2.60)*** | 2.06(1.69, 2.52)*** |
| Male | 155 | 247,273 | 0.63 | 293 | 250,441 | 1.17 | 1.86(1.53, 2.26)*** | 1.61(1.31, 1.97)*** |
| Stratify age | ||||||||
| ≤ 49 | 45 | 111,983 | 0.40 | 107 | 119,112 | 0.90 | 2.22(1.56, 3.14)*** | 2.01(1.39, 2.89)*** |
| 50–65 | 49 | 175,368 | 0.52 | 204 | 178,893 | 1.14 | 2.19(1.71, 2.80)*** | 2.04(1.57, 2.65)*** |
| 65 + | 177 | 234,563 | 0.75 | 334 | 234,839 | 1.42 | 1.87(1.56, 2.25)*** | 1.68(1.38, 2.03)*** |
| Comorbidity‡ | ||||||||
| No | 152 | 311,769 | 0.49 | 196 | 183,995 | 1.07 | 2.18(1.76, 2.69)*** | 2.23(1.80, 2.75)*** |
| Yes | 161 | 210,146 | 0.77 | 449 | 348,848 | 1.29 | 1.66(1.38, 1.98)*** | 1.71(1.43, 2.05)*** |
Rate#, incidence rate, per 1,000 person-years; Crude HR, crude hazard ratio.
Adjusted HR†: multivariable analysis including age, sex, and comorbidities of diabetes, obesity, renal disease, rhematoid arthritis, HIV, and malignancy, untreated hypothyroidism, sleep apnea, narcolepsy, HBV, HCV, depression, anxiety, bipolar affective disorders, schizophrenia, delusional disorders, dementia, anorexia or bulimia nervosa, and alcohol or other substance abuse.
Comorbidity‡: Patients with any one of the comorbidities diabetes, obesity, renal disease, rhematoid arthritis, HIV, malignancy, untreated hypothyroidism, sleep apnea, narcolepsy, HBV, HCV, depression, anxiety, bipolar affective disorders, schizophrenia, delusional disorders, dementia, anorexia or bulimia nervosa, and alcohol or other substance abuse were classified as the comorbidity group.
*p < 0.05, **p < 0.01, ***p < 0.001.